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ABSTRACT
The excessive expansion of white adipose tissue underlies the global obesity epidemic. However, not all
fat is equal, and the impact of heterogeneity on the development and expansion of different adipose
depots is becoming increasingly apparent. Two mechanisms are responsible for the growth of adipose
tissue: hyperplasia (increasing adipocyte number) and hypertrophy (increasing adipocyte size). The
former relies on the differentiation of adipocyte stem cells, which reside within the adipose stromal
vascular fraction. Many differences in gene expression, adipogenesis, and the response to obesogenic
stimuli have been described when comparing adipose stem cells from different depots. Considering
that there is disparity in the pathogenicity of the depots, understanding this heterogeneity has
clinically relevant implications. Here we review the current knowledge surrounding such differences, in
the context of development, expansion and therapeutics. Moreover, given the importance of these
differences, we suggest that careful consideration for the precise methodologies used, is essential if we
are to truly understand the physiologically relevant consequences of this heterogeneity.
KEYWORDS
adipogenesis; adipose
progenitor/stem cell; adipose
heterogeneity; gene
expression; white adipose
tissue
Introduction
Owing to the current worldwide obesity epidemic,
research into adipose tissue biology has increased sub-
stantially over the last few decades. Mammalian adipose
tissue is generally divided into two types: white adipose
tissue (WAT) and brown adipose tissue (BAT). Both
function in the maintenance of energy balance, how-
ever, WAT stores energy in the form of triglycerides,
whereas BAT utilizes lipids to burn energy through
adaptive thermogenesis.1 Importantly, WAT is remark-
ably capable of significant expansion, and it is this
property which can lead to the accumulation of excess
adipose tissue, associated with obesity and related
pathologies.2
Recently, a third form of adipose tissue has also been
identified in rodents. “Beige” or “brite” adipocytes reside
in WAT, but morphologically and functionally they
more closely resemble brown adipocytes. Crucially, they
express uncoupling protein-1 (UCP-1); the master regu-
lator of thermogenesis.3-5 Since the beiging of WAT has
been demonstrated to protect against obesity, this is an
area of much interest.6 Recent excellent reviews have
discussed, in detail, what is currently known about
brown and beige adipose tissue, therefore this will not be
the focus of this review.7-10
WAT is divided into two types: subcutaneous (SWAT),
which is located beneath the skin, and visceral (VWAT)
which is distributed within the body cavity, around the
organs. Excess VWAT, or “bad fat”, is associated with
metabolic disease and the pathologies linked to obesity,
whilst SWAT, or “good fat”, is thought to be protective.11
Both SWAT and VWAT are further subdivided into dis-
tinct depots around the body. To some extent these
depots, or fat pads, differ in location and size between
humans and rodents, and are illustrated in Figure 1.
Increasing evidence demonstrates the vast heteroge-
neity that exists between different adipose depots, and
more specifically, the adipose stem cells (ASCs) isolated
from them.8 Moreover, our recent work has shown that
ASCs isolated from a single VWAT depot, are not a
homogeneous population.12 Given that the different
depots contrast in their pathogenicity, understanding
such differences is clinically relevant. The emphasis of
this review shall be on what is currently known regarding
inter-depot differences between WAT depots, with a
specific focus on the ASCs.
Within the field of adipose tissue biology there are a
multitude of terms that have been used to describe ASCs,
which, when comparing various studies, can become con-
fusing. Examples include “preadipocytes”, “adipocyte
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Edinburgh EH16 4TJ, UK.
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precursor cells” and “adipose mesenchymal stem cells”,
amongst others.13 Considering the ever-increasing hetero-
geneity that is being uncovered between and within ASC
populations, defining clearly the cell type being utilized
will become increasingly important. In recent years there
has been an effort to standardize terminology.13 Neverthe-
less, different terms are still used and with on-going
research, cell surface marker profiles are ever changing
and newly defined populations are being isolated.
Throughout this review the terms ASC, preadipocyte and
adipocyte progenitor will be used interchangeably, accord-
ing to the study being described. Table 1 outlines the dif-
ferent studies that are discussed, including information on
the species, gender, fat depot, health status of the subjects,
and cell type utilized, as well as how the cells were isolated.
Another major area of research in the ASC field focuses
on investigating their potential in regenerative medicine.
There is a growing body of work which aims to compare
subcutaneous ASCs with bone marrow stem cells (BMSCs)
to understand their suitability for therapeutics, which is an
area we shall also discuss. Bone marrow also contains
marrow adipose tissue (MAT) which, unlike visceral and
subcutaneous depots, consists of scattered adipocytes, the
progenitors of which are different from those of WAT/
BAT.14 However, the BMSCs that we henceforth refer to
are the total mesenchymal stem cell (MSC) population as
isolated from bone marrow aspirate.
Variation in gene expression profiles between
white adipose depots
Numerous studies, both human and rodent, have
described differences in gene expression between
subcutaneous and visceral adipose tissue depots when
looking at total fat.15-18 It is hypothesized that differences
between depots influence adipose development as well as
response to environmental cues, such as diet, and are
therefore important in understanding obesity.8 Typically,
such studies in rodents compare inguinal SWAT with
perigonadal VWAT, and in humans, abdominal SWAT
and omental or mesenteric VWAT are compared
(Fig. 1). ASCs reside in the stromal vascular fraction
(SVF) of each depot and in addition to investigating
differences between whole adipose tissue depots, many
groups have specifically examined the isolated SVF, thus
excluding the mature adipocytes from their analysis.19-25
Differential expression of genes implicated
in developmental processes
Gesta et al (2006) compared the gene expression profiles
of the SVF from murine inguinal SWAT and perigonadal
VWAT adipose tissues and showed an enrichment of
genes implicated in developmental processes. When the
SVF was cultured for six days, this differential gene
expression was retained, indicating that the differences
were inherent to the preadipocytes, and not an effect of
the microenvironment in which they exist in vivo. More-
over, when analyzing differences in gene expression
between human abdominal subcutaneous and visceral
adipose tissue, they demonstrated that many of the dif-
ferences observed in the mice were recapitulated in the
human study, and that for certain genes there was a cor-
relation with obesity.26
Much attention has been paid to differences that exist
between subcutaneous and visceral WAT, however,
emerging evidence shows that there is significant varia-
tion between different visceral depots. One of the first
studies to compare gene expression profiles of ASCs
from different human visceral depots revealed that, in
addition to the expected differences between subcutane-
ous and visceral preadipocytes, distinct differences were
observed between mesenteric and omental depots (which
make up the majority of the visceral fat in humans).20 As
with studies that have focused on subcutaneous versus
visceral fat, one major class of genes identified in this
study were those involved in developmental processes,
revealing that surprisingly, mesenteric preadipocytes
clustered with subcutaneous, rather than omental, with
regards to developmental gene expression.20 Similarly,
when gene expression was compared between rat perire-
nal and perigonadal preadipocytes, developmental genes
were one of the main categories identified.21
There is clear evidence that distinct differences in the
expression profiles of developmental genes exist between
all WAT depots in humans and rodents.15,17,20-23,26
Figure 1. Location of human and murine adipose tissue depots.
Depots 1-6 illustrate the visceral white adipose tissue (VWAT).
Depot 7 indicates the subcutaneous white adipose tissue (SWAT):
inguinal in mouse and abdominal, gluteal and femoral in human.
Depot 8 shows the interscapular brown adipose tissue (BAT).
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Yamamoto et al (2010) performed a comprehensive
study investigating differences in the expression of key
developmental genes between total fat from six murine
adipose depots. Having compared the expression of
Tbx15, Shox2, En1, Hoxc9, Hoxc5 and Hoxa5, across
inguinal and interscapular SWAT, as well as perigonadal,
perirenal and mesenteric VWAT and interscapular BAT,
they showed that each depot is distinct, with each one
harboring a unique pattern of developmental gene
expression.27 For example, whilst Shox2 was shown to be
highly expressed in the inguinal SWAT, and not in any
of the VWAT, En1 and Tbx15 were highly expressed in
both subcutaneous fat pads, and additionally in the peri-
renal VWAT, but not in the perigonadal or mesenteric.
Therefore, this study provides supporting evidence for
the discovery that major differences in expression exist
between all depots, thus advocating the idea that adipose
depots exist as individual “mini-organs”.19-21
Differential expression of genes implicated in
adipogenesis, metabolism, inflammation and
angiogenesis
Whilst developmental genes are one of the most com-
monly occurring groups identified through differential
expression analysis, other interesting categories have also
been highlighted. Genes implicated in adipogenesis and
lipid metabolism have been shown to be differentially
expressed among human subcutaneous, mesenteric,
omental and retroperitoneal preadipocytes.20,24,28 For
example, it has been shown that when induced to differ-
entiate in vitro, human subcutaneous preadipocytes
express higher levels of key adipogenic transcription fac-
tors such as PPAR-g and C/EBP-a than omental and
mesenteric preadipocytes.28 Moreover, gene ontology
analysis of microarray data obtained from human
subcutaneous and retroperitoneal ASCs has revealed that
genes involved in cholesterol biosynthesis, lipid metabo-
lism and negative regulation of MAPK activity (which
regulates ASC differentiation) were overexpressed in the
retroperitoneal ASCs.24
Furthermore, genes involved in cellular processes
such as replication and apoptosis, as well as those impli-
cated in transcription, angiogenesis and inflammation
have been highlighted in studies on rodents and
humans.21,24 For example, in rats, proinflammatory
genes were found to be more highly expressed in
perirenal preadipocytes than in perigonadal preadipo-
cytes, a difference which is also more obvious with age.21
This finding is in line with other evidence suggesting
that aging leads to detrimental changes in the function of
adipose tissue.29 Moreover, in terms of secreted adipo-
kines, VWAT is generally considered to secrete more
inflammatory cytokines than SWAT.30 However, differ-
ences also exist between different visceral depots, for
example, the mesenteric depot has been observed to
express higher levels of TNF-a than the omental in insu-
lin resistant individuals.31
In humans, isolated VWAT and SWAT progenitor
cells have also been shown to exhibit different expression
profiles for genes involved in angiogenesis, with retroper-
itoneal VWAT progenitors expressing higher levels of
angiogenic genes than abdominal SWAT progenitors.24
Similarly, VWAT isolated from obese individuals has
been shown to secrete higher levels of VEGF compared
to SWAT from the same subjects, although these studies
examined the whole adipose tissue, rather than the
isolated progenitor cells.32,33 Conversely, in a study uti-
lizing isolated adipose progenitors from human omental
and subcutaneous depots, no significant differences were
observed in the expression of pro-angiogenic or pro-
inflammatory genes such as VEGF, TNF-a and IL-6.34
Comparing differentiation potential in vitro
Evidently, results from gene expression studies indicate
that ASCs from different WAT depots are inherently
different. As discussed in this section, many groups have
used in vitromethods to assess differences in ASC behav-
ior, predominantly proliferation and adipogenic differen-
tiation. We shall discuss whether using the same culture
conditions for ASCs isolated from different depots is
appropriate, for example; perhaps conditions that are
optimal for subcutaneous cells are sub-optimal for vis-
ceral cells, due to their innate differences.
Evidence from human studies
Numerous studies have shown that human SWAT prea-
dipocytes replicate faster and differentiate into adipo-
cytes more efficiently than VWAT preadipocytes
isolated from the same subjects.24,28,34-37 As discussed in
the previous section, SWAT preadipocytes express
higher levels of adipogenic transcription factors, during
differentiation in vitro, than omental and mesenteric.28
A difference has also been observed between omental
and mesenteric depots, with a higher percentage of repli-
cating and differentiating cells in the mesenteric preadi-
pocyte cultures.19,28 Therefore, differences exist between
VWAT depots as well as between SWAT and VWAT.
The key question is why do such differences occur?
From what we have heard so far, an obvious explanation
is that the cells from different depots are inherently dif-
ferent. In addition to this, several other possible reasons
have been addressed. When VWAT and SWAT preadi-
pocytes were co-cultured using transwell inserts, the
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replication of the SWAT cells was not slowed by the
presence of the VWAT, indicating that the difference is
not due to the secretion of anti-replicative factors.19 In
addition to preadipocytes, the SVF contains multiple
non-adipogenic cell types, the percentages of which dif-
fer between depots.38 Nevertheless, the differentiation
capability of colonies derived from single adherent SVF
cells still differs between depots, therefore this disparate
behavior cannot be explained by differences in the pro-
portion of non-adipogenic cells.28 However, it has been
noted that results from studies that analyze colonies
derived from adherent cells should be interpreted with
caution. This method naturally enriches for cells of a
particular immunophenotype, and so is not truly
representative of the heterogeneous population, thus
highlighting the point that analyzing the properties of
adherent SVF cells in vitro is not overly reflective of the
situation in vivo.7,39
As discussed, various studies show that not only do
human SWAT preadipocytes differentiate better than
VWAT, they are also more replicative.24,36 Rodent pre-
adipocytes and pre-adipose cells lines, such as 3T3-L1
cells, should be confluent before they can effectively
differentiate, due to the requirement for growth
arrest.40,41 Therefore, it is logical that more replicative
cells will become confluent more easily and thus differ-
entiate more efficiently. However, this does not appear
to be the case for human preadipocytes, as it has been
shown that they will differentiate without requiring
confluency.41 Consequently, although differences in in
vitro replication and differentiation exist between cells
from different human depots, the later cannot be fully
attributed to the former. Therefore, the differences in
differentiation cannot be fully explained by the differ-
ences in replication.
Contrasting results from human studies
Not all studies performed using human SWAT and
VWAT preadipocytes show the same trend. For example,
work performed by Shahparaki et al (2002), in which
they measured cytosolic glycerol phosphate dehydroge-
nase (GPDH) activity as a determinant of in vitro
terminal adipocyte differentiation,42,43 did not show a
difference in differentiation between cultured omental
and subcutaneous preadipocytes.44 Similarly, another
study which assessed the differentiation of omental and
subcutaneous preadipocytes, by measuring GPDH activ-
ity and counting the number of lipid-filled cells, also
failed to show a difference in differentiation between the
two depots.45 However, proliferation was also assessed,
revealing that subcutaneous cells proliferated at a higher
rate than the omental cells.45
There are several plausible explanations as to why
such inter-experiment differences exist. For example, the
subjects from which the adipose tissue was taken vary
considerably in age, weight, disease status, gender; all fac-
tors which could feasibly influence the condition of the
isolated preadipocytes. Additionally, different groups use
different methods to isolate the preadipocytes. Tradition-
ally, the entire SVF is plated and non-adherent cells are
removed through washing and subsequent passaging,
however as has already been alluded to, there are several
problems with this method ultimately meaning that the
cells used in assays do not well reflect the heterogeneous
nature of the in vivo precursor cell population.39
Moreover, there is much variation between cells used at
different passages, which may account for differences
observed between studies.39 More recent studies use cell
sorting techniques to remove non-adipogenic cells,
rather than relying on adherence/non-adherence;24 how-
ever a panel of suitable markers to permit further enrich-
ment of ASCs from human adipose tissue has not been
established.7 Additionally, there is disparity in how the
cells are differentiated, with different groups using varia-
tions of an adipogenic induction cocktail. Finally, various
methods of determining differentiation are used in
different experiments, including Oil Red O staining,
measuring GPDH activity, quantification of lipid droplet
accumulation and measuring the expression of adipo-
genic genes. With this inter-experiment variation in
mind, it is unsurprising that different studies report
different results, and importantly highlights the require-
ment for more standardized procedures and methods for
the isolation, growth and differentiation of human ASCs.
Evidence from rodent studies
For many years, rodent cell cultures have also been used
to examine differences between SWAT and VWAT, and
between the different visceral depots. In contrast to the
current situation in the human ASC field, panels of
markers that permit the isolation of cells harboring the
properties of adipocyte progenitors and preadipocytes
from the SVF of mice have been identified.46,47 CD45¡;
CD31¡;Ter119¡;CD29C;CD34C;Sca-1C;CD24C SVF
cells, or adipocyte progenitor cells, can form functional
fat depots when transplanted into lypodystrophic mice,
as well as being adipogenic in vitro. CD45¡;CD31¡;
Ter119¡;CD29C;CD34C;Sca-1C;CD24¡ SVF cells (prea-
dipocytes) are derived from the CD24C progenitor cells
and are committed to the adipocyte lineage. Therefore
they are capable of adipogenesis in vitro, but are unable
to form WAT depots in vivo.46,47 Many groups now use
these markers, or a subset of them, to isolate adipocyte
progenitor cells and preadipocytes from mice using flow
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cytometry. Nevertheless, there is still variability within
the field in terms of experimental protocol.
Many studies have shown that, as with human cells,
murine subcutaneous preadipocytes replicate faster and
have greater adipogenic potential than visceral.22,25,48
Additionally, it has been demonstrated that rat perirenal
adipocyte precursor cell cultures have a higher frequency
of replicating and differentiating cells than perigonadal,
therefore highlighting differences between visceral
depots.49-52 Moreover, there is evidence to support that
these differences in the behavior of the precursor cells in
vitro is reflected in the mature adipocytes in vivo, with
the perirenal depot exhibiting a greater increase in fat
cell number over 70 days than the perigonadal depot.51
A recent study that utilized murine subcutaneous and
perigonadal adipocyte precursor cells (isolated based on
the cell-surface marker profile: CD31¡;CD45¡;Ter119¡;
CD34C;Sca-1C) revealed that the addition of BMP4
affects subcutaneous and perigonadal cultures differ-
ently.22 As described previously, the subcutaneous adipo-
cyte precursor cells differentiated very efficiently, with
greater than 90% of the cells forming large lipid droplets,
compared to less than 20% of the perigonadal cells. How-
ever, when the cells were pre-treated with BMP4 before
the addition of the differentiation media, approximately
90% of the perigonadal cells formed lipid droplets, but
no further differentiation in the subcutaneous cultures
was observed. A similar result was seen when BMP2 was
used. Moreover, the expression of genes associated with
differentiated adipocytes, such as Fabp4 and AdipoQ,
increased to levels similar to those recorded for the dif-
ferentiated subcutaneous cells.22 It is well documented
that BMPs can promote the differentiation of mesenchy-
mal stem cells into osteoblasts, chondrocytes and adipo-
cytes.53-55 Further gene expression analysis revealed that,
in the visceral precursor cells, the block in differentiation
occurs because standard differentiation media is unable
to induce the expression of the key adipogenesis gene:
Ppar-g, but that induction of BMP signaling releases this
block. Interestingly, microarray analysis showed that
BMP2 and 4 are expressed at higher levels in the subcu-
taneous precursor cells, compared with the perigonadal,
possibly helping to explain why the subcutaneous cul-
tures did not require the addition of BMP2/4.22 This
study provides an excellent example of how differences
in gene expression between adipocyte precursor cells
from different depots can influence their ability to differ-
entiate into mature adipocytes, and thus how heteroge-
neity between the depots can influence function.
Moreover, this relates to our suggestion that perhaps the
“one-size fits all” approach to culturing ASCs in vitro is
not the best approach, given the inherent differences
between cells from different depots.
Recent work performed by Grandl et al (2016) indi-
cates that the extracellular matrix (ECM) of the adipose
precursor cells influences their differentiation potential.
Having decellularized mouse subcutaneous and perigo-
nadal SVF cultures, and re-seeded them with freshly iso-
lated adipocyte precursor cells, they found that when
perigonadal precursor cells were cultured in the decellu-
larized ECM from the subcutaneous cells, they differenti-
ated better than when cultured in the ECM from the
perigonadal SVF.56 Moreover, it has also been demon-
strated that several proteins which are preferentially
secreted by the perigonadal SVF are capable of inhibiting
adipogenesis, and thus may help to explain why perigo-
nadal adipocyte precursor cells have a lower capacity to
differentiate than subcutaneous.25 Both studies therefore
show strong support for the hypothesis that extracellular
factors impact the differentiation potential of adipocyte
precursor cells. The results from the later study
contradict what has been reported previously, whereby
co-culturing human omental and subcutaneous preadi-
pocytes had no detrimental effect on the replication of
the subcutaneous cells.19 Of course, there are many dif-
ferences between the two studies, not least that one used
murine cells, and the other, human. Furthermore, the
co-culture experiment looked only at whether replication
was affected, not differentiation.
Expansion of adipose tissue in vivo
Many studies that aim to investigate differences in adipo-
genic potential between adipocyte precursor cells from
different depots, and the cellular and molecular mecha-
nisms underlying these differences, have been carried
out in vitro. Nevertheless, the benefits of understanding
such differences in vivo are clear, and recent work has
begun to shift in this direction. In vivo, WAT can expand
through two mechanisms; hypertrophy (an increase in
adipocyte size) and hyperplasia (an increase in adipocyte
number), and it is thought that the mechanism of expan-
sion could influence the depot’s role in the occurrence
and progression of metabolic disease.48 Recent reviews
have described much of the in vivo work in some detail,
including the contrasting results from several studies
that investigated the contributions of hypertrophy and
hyperplasia to the expansion of WAT.7,8 For this reason,
we shall not discuss this area in too much detail, however
it is evident that multiple factors influence the relative
contributions of these two mechanisms to WAT expan-
sion in different depots.
During normal homeostasis there is not much
requirement for hyperplasia or hypertrophy, as the
adipose tissue is not expanding, therefore the majority of
studies are performed under obesogenic conditions. A
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number of studies have demonstrated that hyperplasia
contributes to obesity in rodents,22,48,57,58 and recent
work in humans has revealed that obese individuals have
more adipocytes than lean individuals, which are not lost
following substantial weight loss, indicating that
hyperplasia must play a role in WAT expansion during
obesity.59,60 Regarding differences between adipose
depots recently it has been demonstrated that, following
high-fat feeding, mice exhibit a significant increase in the
formation of new adipocytes in perigonadal VWAT, but
not in SWAT.61,62 This indicates that the visceral depot
expands by hyperplasia in the high-fat diet state, whilst
the subcutaneous depot does not. Moreover, this result
was coupled with data that showed an increase in prolif-
eration of the visceral adipocyte precursor cells in vivo
(but not subcutaneous), within the first week of high-fat
feeding, thus rapidly expanding the pool of precursor
cells available for differentiation into adipocytes. Addi-
tionally, AKT2 signaling in the adipocyte precursor cells
was demonstrated to be required for their activation in
response to the high-fat diet.62 Importantly, it was shown
that these newly formed adipocyte precursor cells in the
VWAT do go on to differentiate into adipocytes after
prolonged high-fat feeding.62 It has also recently been
shown that hyperplasia, rather than hypertrophy, is the
major contributor to the expansion of omental VWAT
in human obesity.60 This data does somewhat contrast to
that from other studies, which have indicated that upon
high-fat feeding, hyperplasia contributes to the expan-
sion of SWAT more so than to the expansion of
VWAT,48 and the number of adipocyte precursor cells is
increased in both visceral and subcutaneous depots.22
There are many potential reasons as to why these studies
obtained contrasting results given that multiple factors
can impact on adipose tissue expansion, such as the age,
strain and sex of the mice, as well as the methods used to
assess adipogenesis (the differentiation of adipocyte pre-
cursor cells into adipocytes). One major difference
between these studies is the length of HFD feeding, with
one focusing on the initial short-term response, and the
other on the long-term response.48,62 Nevertheless, there
is a growing body of evidence that reveals differences in
in vivo adipogenesis between different depots and in dif-
ferent states.
Further work has shown that differences in adipogen-
esis between SWAT and VWAT depots in vivo, depend
on sex.63 Whilst in male mice it appears that adipogene-
sis is increased in VWAT in high-fat diet states, but not
in SWAT, this is not the case in female mice, which
exhibit increased adipogenesis in both the SWAT and
VWAT depots upon high-fat feeding. This result is
thought to be due to the influence of sex-hormones on
adipogenesis, which aligns with the fact that in humans,
men commonly gain visceral adipose tissue, giving the
typical “apple-shaped” figure and premenopausal women
gain subcutaneous adipose tissue, giving the “pear-
shaped” figure, whilst in postmenopausal women there is
a transition to a more male-like adipose distribution.63-65
Moreover, another study which focused on human
SWAT showed that, in women, the contribution of
hyperplasia and hypertrophy to abdominal adipose tissue
gain is dependent on the size of the existing adipocytes.66
If the existing adipocytes were smaller than average,
hypertrophy was the predominant mechanism of expan-
sion, whilst if the existing adipocytes were of average
size, new adipocytes were recruited. However, this was
not the case in men, for whom hypertrophy was the pre-
vailing method of expansion in abdominal SWAT.66
It has also been shown, perhaps surprisingly, that the
proliferation of murine adipocyte precursor cells in
response to high-fat feeding is controlled by cell-extrinsic
factors present in the microenvironment.63 When tdTo-
mato-labelled adipocyte precursor cells isolated from
male SWAT were transplanted into the VWAT of male
mice, both the subcutaneous and visceral cells were
shown to proliferate upon high-fat feeding. Whilst in the
converse experiment, where male VWAT precursor cells
were transplanted into male SWAT, no proliferation was
observed for either cell population upon high-fat stimu-
lation.63 Therefore, in both situations the adipocyte pre-
cursor cells took on the behavior typical of the depot
into which they had been transplanted. Understanding
the regulatory signals governing the activation of the adi-
pocyte precursor cells in obesity is an essential next step,
with evidence already suggesting that sex-hormones may
play a role.63 To some extent this result conflicts with
that from an earlier study, which showed that the trans-
plantation of SWAT into the VWAT region resulted in
decreased weight and fat mass as well as improved glu-
cose metabolism. Therefore indicating that inherent dif-
ferences between the depots, rather than their location,
were responsible for such improvements.67 Obviously
these two studies differ significantly in their approach,
with one transplanting just the precursor cells, and the
other transplanting the total fat tissue. Moreover, the
focus of the precursor cell study was on the proliferative
response to HFD feeding, whereas the total fat transplan-
tation study assessed the consequences for metabolism in
mice fed normal chow.63,67 Nevertheless, both studies are
a powerful reminder of the necessity for in vivo studies.
Regenerative potential of subcutaneous ASCs
The use of mesenchymal stem cells (MSCs) in tissue
repair and immune disorder therapy has increased in
recent years, with many clinical trials currently taking
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place.68 Some of these therapies show promise; for
instance, one MSC based drug, Prochymal, has already
been approved in Canada for the treatment of graft-
versus-host disease and is currently in FDA-approved
Phase III trials for the treatment of Crohn’s disease.69
Historically, the most widely investigated MSCs have
been those isolated from the bone marrow (BMSCs).
However, like BMSCs, subcutaneous ASCs have the poten-
tial to differentiate into many cell types and thus are also
being investigated for use in regenerative therapies. More-
over, subcutaneous ASCs are more readily available as
they can be isolated after lipoaspiration, a procedure which
is both less painful than bone marrow aspiration (which
involves extraction from the hip) and more efficient in
terms of the quantity of stem cells obtained. Stem cells
make up approximately 3% of the adipose tissue SVF in
humans, whereas this figure is just 0.002% for the bone
marrow.70 Multiple studies have compared the differentia-
tion potential of subcutaneous ASCs with that of BMSCs,
in order to assess their suitability for specific therapies. In
this section BMSCs refers to the total MSC population as
isolated from bone marrow aspirate.
Comparing the differentiation potential of BMSCs
and subcutaneous ASCs in a regenerative setting
Much of the work in this area has concentrated on the
potential of these cells to differentiate into lineages
appropriate for application in a regenerative setting.
Although several studies show that subcutaneous ASCs
and BMSCs have similar differentiation potentials, some
differences are noted. Contrasting results have been
obtained from a number of studies that have investigated
the ability of the two populations to differentiate into the
traditional mesenchymal lineages (chondrocytes, adipo-
cytes, osteoblasts).71 Such disparity in the results could
be explained by several factors, including differences in
the sex and age of the patients/model animals and
variation in the methods used by different groups.
The microenvironment influences the ability of BMSCs
and ASCs to differentiate, and in some cases the two cell
types respond differently to the same conditions. The oste-
ogenic potential of BMSCs has been investigated to assess
their suitability for bone-fracture repair. Platelet-derived
growth factor BB (PDGF-BB) is over-secreted in fracture
microenvironments and has previously been found to
inhibit mineralization in BMSC cultures. Surprisingly, a
recent study has shown that PDGF-BB has the opposite
effect in subcutaneous ASC cultures, causing them to pro-
duce more calcium.72 Changes in gene expression in
response to the administration of PDGF-BB were also
found to differ between the two cell types, with the subcu-
taneous ASCs upregulating the expression of osteogenic
genes, whilst in the BMSCs these were downregulated.72
Therefore these results suggest that, in combination with
PDGF-BB, subcutaneous ASCs may be a more suitable
cell type for bone regeneration than BMSCs.
Moreover, subcutaneous ASCs appear to increase
their replicative and osteogenic potential when cultured
on bone marrow-derived extracellular matrix produced
by bone marrow stromal cells.73 Additionally, the two
cell types exhibit contrasting differentiation capabilities
when cultured on 3D bioactive glass-based scaffolds.
Whilst subcutaneous ASCs showed a propensity towards
osteo-differentiation even in the absence of osteogenic
medium, BMSCs failed to differentiate down the osteo-
genic lineage in the absence of osteo-inducing medium.74
Conversely, ASCs cultured in the presence of adipose tis-
sue extracellular matrix tend to undergo adipogenesis
but also do so when no particular cues are present, sug-
gesting that the intrinsic properties of the cells are
important for lineage commitment.75
Some studies have also focused on differentiation into
other therapeutically relevant lineages. For example, human
subcutaneous ASCs and BMSCs have been compared in
terms of their potential to differentiate into pancreatic islet
cells, for the purpose of autologous transplants in the treat-
ment of diabetes. In this case, BMSCs showed an increased
level of insulin secretion, suggesting that they might be bet-
ter suited for the treatment of diabetes.76 On the contrary,
when compared for their muscle regeneration potential in
an in vivo rat abdominal wall reconstruction model, ASCs
showed better proliferation capacity, better angiogenic
potential, as well as good viability even in hypoxic condi-
tions.77 Differences in the secretory phenotype of the two
cell populations have also attracted much attention. For
example, subcutaneous ASCs have been found to be more
suitable than BMSCs for improving left ventricular function
in a mouse myocardial infarction model, through their
paracrine secretion and angiogenic potential.78 On the
other hand, human BMSCs were found to be better than
subcutaneous ASCs at maintaining neuronal function after
cerebral ischemia through the secretion of brain-derived
neurotrophic factor (BDNF).79 Clearly, these two popula-
tions of stem cells differ in their suitability for different ther-
apies, and to a large extent this is likely due to their intrinsic
differences. Nevertheless, multiple studies suggest that sub-
cutaneous ASCs offer a promising alternative to BMSCs in
a therapeutic setting.
Conclusions
Evidently, WAT depots and the ASCs derived from them
are remarkably heterogeneous. Whilst classically the dif-
ferences between SWAT and VWAT have been studied,
there is mounting evidence to show that individual
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VWAT depots are quite different. As we have described,
gene expression profiles differ significantly between the
ASCs from different depots, as well as their differentia-
tion capabilities both in vitro and in vivo.19-21,27,28,49-52
Understanding this heterogeneity and its consequences
in a physiological setting is an essential step in under-
standing why different adipose depots respond differ-
ently to external cues, such as diet.
Much progress has been made over the past decade in
this field, however, it is clear that our knowledge still only
touches the surface of the complexities of this heterogene-
ity. As has been made obvious in this review, there are
many studies that contrast in their results regarding differ-
ences in proliferation, differentiation and interaction with
the microenvironment. It is likely that these differences are
at least partially due to disparity in experimental protocols
and origin of the tissue. We believe that standardization of
protocols, where possible, is necessary if we are to gain an
accurate understanding of the true heterogeneity and the
consequences of it. Moreover, with recent work highlight-
ing that heterogeneity also exists within the ASC population
of a single adipose depot, and that this may have functional
consequences for the adipocytes derived from the ASCs,
the situation is only gettingmore complex.12
Another major field in which ASCs have been investi-
gated is in regenerative medicine. SWAT is an attractive
source of MSCs, due to their abundance and ease of isola-
tion. Many studies have compared subcutaneous ASCs to
BMSCs, which is the traditional source of MSCs for thera-
peutics. As discussed, there are contrasting results in terms
of differentiation potential and therapeutic suitability of
ASCs and BMSCs, depending on the required lineage.
Factors such as the influence of the microenvironment,
and the addition of growth factors affect the behaviors of
the two cell types.72-75,80 Here too, results may be affected
by differences in the isolation, culture and analysis proto-
cols used by different groups, so standardizing the proce-
dures employed may help in reaching a consensus.
The reasons for further studying and characterizing
the different WAT depots, and specifically the ASCs, are
thus twofold. Firstly, the properties of various progenitor
populations may give insight into the pathological
aspects of obesity and obesity-associated diseases. Sec-
ondly, the same properties might prove useful in the
treatment of other unrelated conditions.
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